David A. Siegel Schrodinger, Inc. Transaction History

Two Sigma Advisers, LP

  • $41.3 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$18.09 - $27.61 $1.19 Million - $1.82 Million
-65,900 Reduced 43.85%
84,400 $2.22 Million
Q4 2022

Feb 14, 2023
SELL
$16.24 - $26.38 $199,751 - $324,474
-12,300 Reduced 7.56%
150,300 $2.81 Million
Q3 2022

Nov 14, 2022
BUY
$23.95 - $34.71 $1.14 Million - $1.65 Million
47,400 Added 41.15%
162,600 $4.06 Million
Q2 2022

Aug 15, 2022
SELL
$21.39 - $35.9 $228,873 - $384,130
-10,700 Reduced 8.5%
115,200 $3.04 Million
Q1 2022

May 16, 2022
SELL
$24.84 - $36.12 $96,876 - $140,868
-3,900 Reduced 3.0%
125,900 $4.3 Million
Q4 2021

Feb 14, 2022
BUY
$33.38 - $59.25 $3.17 Million - $5.62 Million
94,900 Added 271.92%
129,800 $4.52 Million
Q3 2021

Nov 15, 2021
BUY
$53.75 - $76.55 $1.32 Million - $1.88 Million
24,600 Added 238.83%
34,900 $1.91 Million
Q2 2021

Aug 16, 2021
BUY
$59.02 - $78.8 $607,906 - $811,640
10,300 New
10,300 $779,000
Q1 2021

May 17, 2021
SELL
$64.61 - $113.09 $5.03 Million - $8.81 Million
-77,900 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$48.06 - $84.4 $1.19 Million - $2.09 Million
-24,800 Reduced 24.15%
77,900 $6.17 Million
Q3 2020

Nov 16, 2020
BUY
$46.87 - $93.33 $4.81 Million - $9.58 Million
102,700 New
102,700 $4.88 Million

Others Institutions Holding SDGR

# of Institutions
235
Shares Held
60.7M
Call Options Held
726K
Put Options Held
329K
View Full List

About Schrodinger, Inc.

SDGR Quotes by TradingView
  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.23B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email